Patty W. Wright
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 7
- Antifungal resistance and susceptibility 6
- SARS-CoV-2 and COVID-19 Research 3
- Epidemiology 14
- Fungal Infections and Studies 4
- Co-authors
- Thomas R. Talbot (9 shared papers)Geraldine G. Miller (3 shared papers)Karen C. Bloch (5 shared papers)John W. Gnann (2 shared papers)Robert W. Bradsher (1 shared paper)Peter G. Pappas (2 shared papers)J Ryan Bariola (1 shared paper)Matthew Robinson (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (6 papers)Clinical Infectious Diseases (5 papers)Open Forum Infectious Diseases (4 papers)Journal of Clinical Microbiology (2 papers)BMJ Open (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Patty W. Wright
30 papers receiving 662 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 342
- Clinical Biochemistry 118
- Microbiology 8
- Epidemiology 366
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Patty W. Wright
This map shows the geographic impact of Patty W. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patty W. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patty W. Wright more than expected).
Fields of papers citing papers by Patty W. Wright
This network shows the impact of papers produced by Patty W. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patty W. Wright. The network helps show where Patty W. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Patty W. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 98 | |
| 2 | 2009 | 58 | |
| 3 | 2017 | 58 | |
| 4 | 2011 | 51 | |
| 5 | 2012 | 47 | |
| 6 | 2018 | 46 | |
| 7 | 2017 | 43 | |
| 8 | 2003 | 39 | |
| 9 | 2014 | 35 | |
| 10 | 2021 | 33 | |
| 11 | 2018 | 30 | |
| 12 | 2012 | 27 | |
| 13 | 2018 | 22 | |
| 14 | 2020 | 19 | |
| 15 | 2014 | 18 | |
| 16 | 2016 | 9 | |
| 17 | 2007 | 8 | |
| 18 | 2018 | 8 | |
| 19 | 2010 | 6 | |
| 20 | 2017 | 6 |
About Patty W. Wright
Patty W. Wright is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Surgery and Clinical Biochemistry, having authored 36 papers that have together received 685 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antifungal resistance and susceptibility (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Fungal Infections and Studies (4 papers), Orthopedic Infections and Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Surgical site infection prevention (2 papers). The work is most often cited by research in Infectious Diseases (342 citations), Clinical Biochemistry (118 citations), Microbiology (8 citations), Epidemiology (366 citations) and Applied Microbiology and Biotechnology (16 citations). Patty W. Wright has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Thomas R. Talbot, Geraldine G. Miller, Karen C. Bloch, John W. Gnann, Robert W. Bradsher, Peter G. Pappas, J Ryan Bariola, Matthew Robinson, Laurie A. Proia and George E. Nelson. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Open Forum Infectious Diseases, Journal of Clinical Microbiology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.